The instruments segment by product is estimated to lead the market growth during the forecast period.

According to a new market research study of “Europe Tissue Sectioning Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product, Technology, Application, End User and Country.” The Europe tissue sectioning market is expected to reach US$ 256.26 million by 2028 from US$ 169.87 million in 2021; it is estimated to grow with a CAGR of 6.0% from 2021 to 2028. The report highlights trends prevailing in the Europe tissue sectioning market and the factors driving market along with those that act as hindrances.

Personalized or precision medicine has become the hallmark of treatment for various severe diseases and has expanded to other fields with its application. It is a constantly emerging approach to customizing therapies based on patients' genetic accumulation. These technological advancements have led to tissue sectioning approaches that achieve better results with the available resources in less time. For the prevention and efficient treatment of a disease, personalized medicines are mandatory tools, especially in oncology and nephrology cases.

The rapidly increasing cancer cases indirectly contribute to this market. For instance, as per the WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million demises in 2020. The most common types of cancer are lung cancer, liver cancer, blood cancer, and breast cancer. Between 30% and 50% of cancers can currently be prevented through early cancer diagnosis and appropriate treatment and care of patients. According to the WHO, several types of cancers are likely to be cured if diagnosed early and treated appropriately. The increasing use of personalized medicine has prompted the use of human tissue use to foster innovative tests.

Countries in the European region have been significantly affected due to the COVID-19 pandemic. Histopathology & cytopathology sample handling protocols have been changed. In the article Journal of Histotechnology from Informa UK Limited, Coronavirus disinfection in histopathology has emphasized the sample handling procedures for all healthcare experts. The Guidelines from OSHA (Occupational Safety and Health Administration) Bloodborne Pathogens guidelines and the World Health Organization (WHO) recommendations, the precautions to ensure maximum protection while handling specimens received in the laboratory.

Moreover, all precautions are taken to prevent exposure to the virus. A European perspective research study was conducted on cellular pathology in the COVID-19 era on maintaining quality and safety. This report highlights that the COVID-19 pandemic significantly impacted diagnostic laboratories, particularly those that handled cells and tissue specimens, and recommended suggestions. For instance, specimen handling, processing, and analysis should transport in transport boxes, and all surfaces and equipment be cleaned with an appropriate disinfectant. Therefore, the demand for tissue sectioning in the Europe market is likely to grow slower during COVID -19 situation, owing to the government initiatives in tissue sectioning research.

Based on the product, the Europe tissue sectioning market is segmented into instruments, accessories & consumables, and services. The instruments segment is further sub-segmented into rotary microtome, ultramicrotome, cryostat, sliding microtome, and others. Based on the technology, the Europe tissue sectioning market is segmented into automatic, semiautomatic, and manual. Based on application, the North America tissue sectioning market is segmented into diagnosis and research. The Europe tissue sectioning market is segmented into hospitals, clinics, diagnostic laboratories, digital path labs, and others based on the end user. Geographically, the Europe tissue sectioning market is sub-segmented into Germany, UK, Italy, Spain, and France.

THERMO FISHER SCIENTIFIC, INC., Leica Biosystems Nussloch GmbH (Danaher), Diapath S.p.A, Histo-Line Laboratories, SLEE medical GmbH, Abcam Plc, Amos Scientific Pty Ltd, SAKURA FINETEK EUROPE B.V, MEDITE Medical GmbH and LLS ROWIAK LaserLabSolutions GmbH are among the leading companies operating in the Europe tissue sectioning market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com